RU2004127918A - Сложный тиоэфир линейной олигомолочной кислоты - Google Patents

Сложный тиоэфир линейной олигомолочной кислоты Download PDF

Info

Publication number
RU2004127918A
RU2004127918A RU2004127918/04A RU2004127918A RU2004127918A RU 2004127918 A RU2004127918 A RU 2004127918A RU 2004127918/04 A RU2004127918/04 A RU 2004127918/04A RU 2004127918 A RU2004127918 A RU 2004127918A RU 2004127918 A RU2004127918 A RU 2004127918A
Authority
RU
Russia
Prior art keywords
group
compound
formula
salt
hydrogen atom
Prior art date
Application number
RU2004127918/04A
Other languages
English (en)
Russian (ru)
Inventor
Микио ВАТАНАБЕ (JP)
Микио ВАТАНАБЕ
Масахиро МУРАКАМИ (JP)
Масахиро МУРАКАМИ
Original Assignee
Амато Фармасьютикал Продактс, Лтд. (Jp)
Амато Фармасьютикал Продактс, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амато Фармасьютикал Продактс, Лтд. (Jp), Амато Фармасьютикал Продактс, Лтд. filed Critical Амато Фармасьютикал Продактс, Лтд. (Jp)
Publication of RU2004127918A publication Critical patent/RU2004127918A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/22Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
RU2004127918/04A 2002-02-19 2003-02-18 Сложный тиоэфир линейной олигомолочной кислоты RU2004127918A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002042008 2002-02-19
JP2002-42008 2002-02-19

Publications (1)

Publication Number Publication Date
RU2004127918A true RU2004127918A (ru) 2005-04-10

Family

ID=27799986

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004127918/04A RU2004127918A (ru) 2002-02-19 2003-02-18 Сложный тиоэфир линейной олигомолочной кислоты

Country Status (10)

Country Link
US (1) US20050222420A1 (zh)
EP (1) EP1484319A4 (zh)
JP (1) JPWO2003076404A1 (zh)
KR (1) KR20040085202A (zh)
CN (1) CN1646492A (zh)
AU (1) AU2003211386A1 (zh)
CA (1) CA2480001A1 (zh)
RU (1) RU2004127918A (zh)
TW (1) TW200303299A (zh)
WO (1) WO2003076404A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4655496B2 (ja) * 2004-04-01 2011-03-23 東レ株式会社 ポリエステル樹脂配合用エステル化合物
RU2527471C1 (ru) * 2013-04-19 2014-08-27 Федеральное государственное унитарное предприятие "Научно-исследовательский институт химии и технологии полимеров имени академика В.А. Каргина с опытным заводом" (ФГУП "НИИ полимеров") Полиэфирполикарбонаты олигомолочной кислоты

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS552264B2 (zh) * 1973-12-24 1980-01-19
JPS585163B2 (ja) * 1975-02-25 1983-01-29 三井東圧化学株式会社 サツソウザイ
CH618322A5 (zh) * 1975-08-25 1980-07-31 Ciba Geigy Ag
CH620339A5 (zh) * 1976-03-05 1980-11-28 Ciba Geigy Ag
GB1588731A (en) * 1977-03-09 1981-04-29 Ici Ltd Cotton desiccation with phenoxyalkanoic acids
JPS60149554A (ja) * 1984-01-13 1985-08-07 Hokko Chem Ind Co Ltd 3,4−ジクロルベンジルチオ−ルエステル誘導体および土壌殺菌剤
AU779592B2 (en) * 1999-08-09 2005-02-03 Amato Pharmaceutical Products, Ltd. Therapeutic agent for diabetes
EP1219616A4 (en) * 1999-09-20 2002-11-06 Amato Pharm Prod Ltd PROCESS FOR THE PREPARATION OF CYCLIC LACTIC ACID OLIGOMERS
CA2385321A1 (en) * 1999-09-20 2001-03-29 Mikio Watanabe Method for producing cyclic lactic acid oligomer
CA2383152A1 (en) * 1999-09-20 2001-03-29 Tamotsu Terao Agent for enhancing stamina and agent for promoting glycogen accumulation
WO2001039782A1 (fr) * 1999-12-03 2001-06-07 Amato Pharmaceutical Products, Ltd. Agent de radioprotection
WO2001054705A1 (fr) * 2000-01-26 2001-08-02 Amato Pharmaceutical Products, Ltd. Inhibiteurs d'implantation de cellules cancereuses
US20040110834A1 (en) * 2001-01-12 2004-06-10 Masahiro Murakami Preventives for microbial infections
EP1358885A1 (en) * 2001-01-12 2003-11-05 Amato Pharmaceutical Products, Ltd. Antiallergic agents
EP1362594A1 (en) * 2001-01-24 2003-11-19 Amato Pharmaceutical Products, Ltd. Anti-stress agents
JP2002265420A (ja) * 2001-03-13 2002-09-18 Tendou Seiyaku Kk 鎖状オリゴ乳酸エステル
JP2002275256A (ja) * 2001-03-19 2002-09-25 Tendou Seiyaku Kk 乳酸オリゴマーの製造方法

Also Published As

Publication number Publication date
US20050222420A1 (en) 2005-10-06
KR20040085202A (ko) 2004-10-07
EP1484319A4 (en) 2007-01-24
CA2480001A1 (en) 2003-09-18
CN1646492A (zh) 2005-07-27
EP1484319A1 (en) 2004-12-08
JPWO2003076404A1 (ja) 2005-07-07
WO2003076404A1 (fr) 2003-09-18
TW200303299A (en) 2003-09-01
AU2003211386A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
ATE302001T1 (de) Stabilisierte askorbinsäurederivate
RU98119523A (ru) Соединения пиперазина и пиперидина
RU2010107684A (ru) Конденсированные гетероциклы
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
DK1323710T3 (da) Nitrogenholdige femleddede ringforbindelser
EP1492173A3 (en) Light emitting device containing a rare earth complex as luminescent medium
CA2700319A1 (en) Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
RU2004106617A (ru) Противоопухолевые аналоги
EP1634874A4 (en) imidazolidine
FI952101A (fi) Merkaptopyrrolidin-2-tioni
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
MX2010001344A (es) Compuesto de acido fenilacetico.
MY143665A (en) Method of producing aminophenol compounds.
HK1078586A1 (en) Carbacyclic phosphatidic acid derivative
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
RU2004127918A (ru) Сложный тиоэфир линейной олигомолочной кислоты
JP4184672B2 (ja) 第4級アンモニウム水酸化物含有組成物及びその製造法
ATE321552T1 (de) 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
EP1595863A4 (en) QUATERNARY AMMONIUM SALTS
ATE420068T1 (de) Reverse hydroxamsäurederivate
SE7903687L (sv) Cyklohexylkarboxylsyraderivat och sett att framstella desamma
EA200300997A1 (ru) Линейный олиголактатный сложный эфир
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
EA199900528A1 (ru) Новые производные эритромицина, способ их получения и применения в качетве медикаментов

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20060519